Top Markets
#1 Bedrock Bedrock +62.98%
#2 Naoris Protocol Naoris Protocol +22.37%
#3 DeFiChain DeFiChain +19.78%
#4 ETHGas ETHGas +18.84%
#5 pippin pippin +17.77%
#6 Irys Irys +16.70%
#7 IQ IQ +15.49%
#8 DUSK Network DUSK Network +15.44%
#9 Buttcoin Buttcoin +12.54%
#10 Magma Finance Magma Finance +12.26%
Coin of the day
Bedrock Bedrock
Settings
Language
ENGLISH
Currency
USD
Theme
Roche Holding AG Roche Holding AG

Roche Holding AG

ROG
Rank in Stocks #35
Roche Holding AG engages in the pharmaceuticals and diagnostics businesses in... Roche Holding AG engages in the pharmaceuticals and diagnostics businesses in Switzerland, Germany, the United States, Austria, Netherlands, the United Kingdom, France, Belgium, and internationally. The company offers pharmaceutical products for treating oncology, neuroscience, infectious, immunology, cardiovascular and metabolism, ophthalmology, and respiratory, as well as anemia, cancer, dermatology, hemophilia, inflammatory and autoimmune, neurological, and transplantation. It also offers in vitro tests for the diagnosis of various diseases, such as cancer, diabetes, Covid-19, hepatitis, human papillomavirus, and other diseases. In addition, the company supplies diagnostic instruments and reagents. The company was founded in 1896 and is headquartered in Basel, Switzerland.
Share Price
$419.17
Market Cap
$333.66B
Change (1 day)
0.50%
Change (1 year)
21.90%
Country
CH
Trade Roche Holding AG (ROG)

Category

Healthcare
P/E ratio for Roche Holding AG (ROG)
P/E ratio as of March 2026 TTM: 19.82
According to Roche Holding AG latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is 19.82. At the end of 2026 the company had a P/E ratio of 0.
P/E ratio history for Roche Holding AG from 2026 to 2026
P/E ratio at the end of each year
Year P/E Ratio Change
Not enough data for the provided dates.
P/E ratio for similar companies or competitors
Company P/E Ratio P/E Ratio Difference Country
How to read a P/E ratio?

The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share.
A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.

Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.

Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.